Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Fingolimod therapy modulates circulating B cell composition, increases B regulatory subsets and production of IL-10 and TGFβ in patients with Multiple Sclerosis.
Acid-sensing ion channels: trafficking and synaptic function.
Ibuprofen-induced unilateral optic neuritis.
Deletion of IL-4Rα in the BALB/c mouse is associated with altered lesion topography and susceptibility to experimental autoimmune encephalomyelitis.
T cell vaccination benefits relapsing progressive multiple sclerosis patients: a randomized, double-blind clinical trial.
Purkinje cell pathology and loss in multiple sclerosis cerebellum.
Heat shock protein 27 in multiple sclerosis relapses.
Glycoengineering of Interferon-β 1a Improves Its Biophysical and Pharmacokinetic Properties.
Development and assessment of a website presenting evidence-based information for people with multiple sclerosis: the IN-DEEP project.
Acute reversible periependymal ventricular enhancement in neuromyelitis optica.
Natalizumab discontinuation and disease restart in pregnancy: a case series.
Human T cell expansion and experimental autoimmune encephalomyelitis inhibited by Lenaldekar, a small molecule discovered in a zebrafish screen.
Merck KGaA Reaches Mutual Agreement with Ono Pharmaceutical to Terminate the License Agreement on Ceralifimod (ONO-4641)
Survey results show that adults are willing to pay higher insurance premiums for generous coverage of specialty drugs.
Antiretroviral activity, pharmacokinetics, and tolerability of MK-0518, a novel inhibitor of HIV-1 integrase, dosed as monotherapy for 10 days in treatment-naive HIV-1-infected individuals.
Total-tau in cerebrospinal fluid of patients with multiple sclerosis decreases in secondary progressive stage of disease and reflects degree of brain atrophy.
Value of NMO-IgG determination at the time of presentation as CIS.
Decreased urinary level of melatonin as a marker of disease severity in patients with multiple sclerosis.
Increased promoter methylation of the immune regulatory gene SHP-1 in leukocytes of multiple sclerosis subjects.
XIMINO (minocycline hydrochloride) capsule, extended release [Ranbaxy Laboratories Inc.]
Adult mesenchymal stem cell therapy for myelin repair in Multiple Sclerosis.
Pathogenic and regulatory roles for B cells in experimental autoimmune encephalomyelitis.
Immunological and clinical consequences of splenectomy in a multiple sclerosis patient treated with natalizumab.
Efficacy and safety of subcutaneous interferon-β-1a in patients with a first demyelinating event and early multiple sclerosis.
Decreased signal transducers and activators of transcription (STAT) protein expression in lymphatic organs during EAE development in mice.

Pages